Practice News

The following news announcements provide information about what's going on at Virginia Cancer Specialists — from the latest research studies and technological advances to the addition of new physicians and staff members. Click on any news release link below to review.

Dr. Neelima Denduluri Selected for ASCO Leadership Development Program

Mar 15, 2016

Virginia Cancer Specialists would like to congratulate Dr. Neelima Denduluri for being selected to participate in the esteemed American Society of Clinical Oncology (ASCO) Leadership Development Program for years 2016-2017.... Read More

VCS Research Institute is Participating in a Phase 2 Study of Entrectinib

Mar 11, 2016

Virginia Cancer Specialists would like to inform you, that our practice is participating in a Phase 2 basket study of entrectinib (also known as RXDX-101), a novel inhibitor of the... Read More

Virginia Cancer Specialists Urges Men and Women to Get Screened for Colorectal Cancer

Mar 1, 2016

FAIRFAX, Va.--(BUSINESS WIRE)--Virginia Cancer Specialists (VCS), the premiere cancer treatment center in Northern Virginia and a practice in The US Oncology Network, reminds the community that... Read More

FDA Approves the Drug Eribulin for Liposarcoma

Feb 18, 2016

The drug eribulin mesylate (Halaven) has been approved by the FDA for the treatment of advanced or unresectable liposarcoma in patients after they have completed anthracycline-based chemotherapy treatment. The approval... Read More

Seventeen VCS Physicians Named to Northern Virginia Magazine’s 2016 Top Doctors List

Feb 5, 2016

The much-anticipated Top Doctors issue of local publication Northern Virginia Magazine has recently been released, and Virginia Cancer Specialists is pleased to have 17 physicians named to the Top Doctors list.... Read More

Dr. Dipti Patel-Donnelly Appears on Fox 5 News in Honor of World Cancer Day 2016

Feb 5, 2016

Each year, in order to gain increased awareness about cancer and its treatment and prevention, February 4 has been named World Cancer Day.  In honor of this occasion, Virginia Cancer... Read More

VCS Research Institute Trial Participation Helps Contribute to Ground-Breaking FDA Drug Approvals

Dec 7, 2015

October and November 2015 were exciting months in the world of cancer research and clinical trials. The FDA recently announced approvals of several new therapies that have been undergoing rigorous study,... Read More

Dr.  Neelima Denduluri Contributing Author of MERiDiAN Poster Presented at ESMO Conference in Vienna

Nov 10, 2015

Virginia Cancer Specialists’ Dr. Neelima Denduluri was a coauthor on the MERiDiAN study presented at the European Cancer Congress. The study explored the efficacy of paclitaxel with and without... Read More

Multiple Myeloma Research Foundation reaches an unprecedented 1,000 patient enrollment milestone

Sep 30, 2015

Virginia Cancer Specialists (VCS) is proud to announce that the Multiple Myeloma Research Foundation’s CoMMpass Study has reached 1000 patients-- a full enrollment and new milestone!  Throughout the... Read More

Dr. Robert Christie of VCS contributes knowledge of bone cancer to Live Science

Sep 30, 2015

Robert Christie, M.D., F.A.C.P., Medical Oncologist and Hematologist at VCS, was recently quoted in an article by Live Science, titled Skeletal System: Facts, Function and Disease.... Read More